Article
CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
The Prostate - 1 Jan 2021
Zhu Yini, Wen Jiling, Huang Gang, Mittlesteadt Jackson, Wen Xiaofei, Lu Xin
Abstract excerpt
BACKGROUND: Recent genomic profiling has identified a subtype of prostate cancer (PCa) characterized by two key genetic alterations: missense mutation of speckle-type POZ protein (SPOP) and homozygous deletion of chromodomain helicase DNA-binding protein 1 (CHD1). Mutually exclusive with E26 transformation-specific (ETS) rearrangements, this subtype displays high genomic instability. Previous studies indicate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
